Organon Pharmaceutical is a global healthcare company focused on improving the health of women throughout their lives. They generate revenue through the development, manufacturing, and marketing of a diverse portfolio of medicines and products in areas such as reproductive health, heart disease, dermatology, allergies, and asthma. Founded in 2021 as a spin-off from Merck & Co., Organon leverages decades of expertise and a robust pipeline to address unmet medical needs. Their commitment to innovation and patient care positions them as a leader in women's health and beyond.